EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study

Abhishek Deshpande iD, Rebecca Schulte, Ramara E Walker iD, Andrea M Pallotta, Ming Wang iD, Sameer S Kadri iD, Sarah Haessler iD, Michael Klompas iD, Peter K Lindenauer, Michael B Rothberg

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag165 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Abhishek Deshpande und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Procalcitonin, Community-Acquired Pneumonia, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NIH HHS, US Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Procalcitonin (PCT) testing may guide antibiotic decisions in community-acquired pneumonia (CAP), but real-world evidence of its impact on antibiotic prescribing in the era of shorter antibiotic courses remains limited.

Methods

We conducted a retrospective cohort study of adults with CAP admitted to the wards of 12 hospitals between November 2022 and January 2025. Primary analyses included: (1) PCT testing rates at admission, (2) the association between PCT testing and duration of antibiotic therapy, and (3) among patients initiated on extended-spectrum antibiotics (ESAs), the relationship between PCT results and early de-escalation. We compared outcomes between PCT-tested and untested patients and between those with low (<0.1 μg/L) vs high (≥0.1 μg/L) PCT values using propensity score overlap weighting to control for potential confounders.

Results

Among 17 290 non–intensive care unit (ICU) admissions for CAP, PCT testing was performed for 10 658 patients (59.5%) within 24 hours of admission. After adjustments, PCT testing was associated with shorter antibiotic duration (adjusted mean difference, −0.32 days; 95% confidence interval [CI], −.52 to −.12) but was not significantly associated with ESA de-escalation compared with no PCT testing (hazard ratio, 1.05; 95% CI, .99–1.12). Patients with low PCT values received shorter antibiotic courses compared with those with high values (adjusted mean difference, −0.56 days; 95% CI, −.85 to −.49).

Conclusions

In non-ICU patients with CAP, PCT testing was associated with modest differences in antibiotic duration, primarily when values were low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProcalcitoninCommunity-Acquired PneumoniaAnti-Bacterial AgentsHumansRetrospective StudiesFemaleMaleAgedMiddle AgedHospitalizationAntimicrobial StewardshipAged, 80 and overCommunity-Acquired Infections

Stichwörter der Autor:innen

antibiotic stewardshipcommunity-acquired pneumoniaprocalcitoninviral pneumonia

Substanzen

ProcalcitoninAnti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Medical Education, Alice L Walton School of Medicine, Bentonville, Arkansas, USA.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.

ORCID-Profile: Abhishek Deshpande, Ramara E Walker, Ming Wang, Sameer S Kadri, Sarah Haessler, Michael Klompas

Förderung

  • AHRQ HHS
  • NIH HHS
  • US Department of Health and Human Services
  • Agency for Healthcare Research and Quality
  • National Institutes of Health

Zitieren

APA

Deshpande, A., Schulte, R., Walker, R. E., Pallotta, A. M., Wang, M., Kadri, S. S., Haessler, S., Klompas, M., Lindenauer, P. K., & Rothberg, M. B. (2026). Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag165

Vancouver

Deshpande A, Schulte R, Walker RE, Pallotta AM, Wang M, Kadri SS, et al. Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag165

BibTeX
@article{Deshpande2026,
  author = {Deshpande, Abhishek and Schulte, Rebecca and Walker, Ramara E and Pallotta, Andrea M and Wang, Ming and Kadri, Sameer S and Haessler, Sarah and Klompas, Michael and Lindenauer, Peter K and Rothberg, Michael B},
  title = {Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag165}
}
Kostenlos starten →